|
Each ml contains:
Composition:
Methylergometrine Maleate
IP….................................….0.2
mg
Water for injection
IP…............................................................q.s.
Indications:
Oral: Post-partum, haemorrhage, uterine
atony, menorrhagia, menopausal
haemorrhage, stubborn & prolonged
uterine inertia. In association with
caesarean section, following abortion,
lochiometra, puerperal bleeding.
Description:
Methylergonovine maleate (Methergine®),
an ergot derivative with
vasoconstrictive properties, has been
cited as an effective treatment for
vascular headaches. Few studies are
available to support its use in headache
management. An uncontrolled pilot study
of 20 episodic cluster headache patients
confirmed its effectiveness and
tolerability as an adjunct cluster
headache prophylactic. Decreased
headache frequency was reported by 19 of
20 patients (95%), and 15 of 20 patients
(75%) reported decreased intensity of
headaches within 1 week of initiating
therapy. A review of methylergonovine's
pharmacokinetic, molecular, and
tolerability profile clarifies its
mechanisms and clinical role in headache
management.
Dosage : As
per the physician’s advice.
Presentations :
MRP Retailer Stockiest
25.00
20.00 18.00
Wallpapers:
|
